blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3757090

EP3757090 - NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  10.05.2024
Database last updated on 30.09.2024
FormerGrant of patent is intended
Status updated on  26.03.2024
FormerExamination is in progress
Status updated on  06.10.2023
FormerRequest for examination was made
Status updated on  19.11.2021
FormerThe application is deemed to be withdrawn
Status updated on  05.11.2021
FormerRequest for examination was made
Status updated on  08.10.2021
FormerThe application has been published
Status updated on  27.11.2020
Most recent event   Tooltip10.05.2024(Expected) grantpublished on 12.06.2024  [2024/24]
Applicant(s)For all designated states
Arbutus Biopharma Corporation
25th Floor
700 West Georgia Street
Vancouver, BC V7Y 1B3 / CA
[2023/24]
Former [2021/01]For all designated states
Arbutus Biopharma Corporation
100- 8900 Glenlyon Parkway
Burnaby, BC V5J 5J8 / CA
Inventor(s)01 / Manoharan, Muthiah
c/o Alnylam Pharmaceuticals Inc.
300 Third Street
Cambridge, MA Massachusetts 02142 / US
02 / Jayaraman, Muthusamy
c/o Alnylam Pharmaceuticals Inc.
300 Third Street
Cambridge, MA Massachusetts 02142 / US
03 / Rajeev, Kallanthottathil, G.
c/o Alnylam Pharmaceuticals Inc.
300 Third Street
Cambridge, MA Massachusetts 02142 / US
04 / Eltepu, Laxman
c/o Alnylam Pharmaceuticals Inc.
300 Third Street
Cambridge, MA Massachusetts 02142 / US
05 / Ansell, Steven
c/o Alnylam Pharmaceuticals Inc.
300 Third Street
Cambridge, MA Massachusetts 02142 / US
06 / Chen, Jianxin
c/o Alnylam Pharmaceuticals Inc.
300 Third Street
Cambridge, MA Massachusetts 02142 / US
 [2021/01]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[2024/24]
Former [2021/01]Müller-Boré & Partner Patentanwälte PartG mbB
Friedenheimer Brücke 21
80639 München / DE
Application number, filing date20177336.310.11.2009
[2021/01]
Priority number, dateUS20080113179P10.11.2008         Original published format: US 113179 P
US20090154350P20.02.2009         Original published format: US 154350 P
US20090171439P21.04.2009         Original published format: US 171439 P
US20090185438P09.06.2009         Original published format: US 185438 P
US20090225898P15.07.2009         Original published format: US 225898 P
US20090234098P14.08.2009         Original published format: US 234098 P
[2021/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3757090
Date:30.12.2020
Language:EN
[2020/53]
Type: A9 Corrected patent application 
No.:EP3757090
Date:19.07.2023
[2023/29]
Type: B1 Patent specification 
No.:EP3757090
Date:12.06.2024
Language:EN
[2024/24]
Search report(s)(Supplementary) European search report - dispatched on:EP21.09.2020
ClassificationIPC:C07D317/46, A61K31/713, A61P33/00, A61K9/127, A61K31/7088, A61P37/04, C07D203/10, C07D317/28, C07D317/44, C07D405/12, C07D317/72, C07D491/056, A61K39/00, A61P35/00, C07D319/06, C07D491/113, C12N15/11
[2024/16]
CPC:
A61K9/1272 (EP,CN,IL,KR,US); A61K47/44 (IL,KR,US); A61K47/543 (KR);
A61K47/10 (CN,IL,KR,US); A61K31/7088 (EP,CN,IL,KR,US); A61K31/7105 (CN,KR);
A61K31/713 (EP,CN,IL,KR,US); A61K39/00 (EP,CN,IL,US); A61K39/39 (IL,KR,US);
A61K47/18 (CN,IL,KR,US); A61K47/20 (CN,IL,KR,US); A61K47/22 (CN,KR);
A61K47/28 (CN,IL,KR,US); A61K48/0033 (CN,KR); A61K9/5123 (KR);
A61P33/00 (EP,IL,KR); A61P35/00 (EP,IL,KR); A61P37/04 (EP,IL,KR);
C07C219/06 (KR); C07C219/20 (KR); C07C229/08 (IL,KR,US);
C07C229/30 (IL,KR,US); C07C237/16 (IL,KR,US); C07C251/38 (IL,KR,US);
C07C251/78 (IL,KR,US); C07C271/12 (IL,KR,US); C07C271/20 (IL,KR,US);
C07C323/25 (IL,KR,US); C07D203/10 (EP,IL,KR,US); C07D233/64 (KR);
C07D317/28 (EP,IL,KR,US); C07D317/44 (EP,IL,US); C07D317/46 (EP,IL,KR,US);
C07D317/72 (EP,IL,KR,US); C07D319/06 (EP,IL,KR,US); C07D405/12 (EP,IL,KR,US);
C07D491/056 (EP,IL,KR,US); C07D491/113 (EP,IL,KR,US); C07F9/65515 (KR);
C12N15/111 (EP,CN,IL,KR,US); C12N15/113 (IL,KR,US); A61K2039/55555 (CN,IL,KR,US);
A61K2039/55561 (CN,IL,KR,US); C12N2310/14 (CN,IL,KR,US); C12N2310/3515 (CN,IL,KR,US);
C12N2320/32 (CN,IL,KR,US); Y02A50/30 (EP,IL,KR,US) (-)
Former IPC [2021/01]C07D203/10, C07D317/28, C07D317/44, C07D317/72, C07D319/06, C07D405/12, C07D491/056, C07D491/113, A61K47/00, A61K31/01
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2021/45]
Former [2021/01]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
TitleGerman:NEUARTIGE LIPIDE UND ZUSAMMENSETZUNGEN ZUR VERABREICHUNG VON THERAPEUTIKA[2021/01]
English:NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS[2021/01]
French:NOUVEAUX LIPIDES ET COMPOSITIONS D'ADMINISTRATION D'AGENTS THÉRAPEUTIQUES[2021/01]
Examination procedure01.07.2021Application deemed to be withdrawn, date of legal effect  [2021/49]
30.09.2021Amendment by applicant (claims and/or description)
30.09.2021Examination requested  [2021/45]
deletedDeletion: Application deemed to be withdrawn, date of legal effect  [2021/51]
22.07.2021Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2021/51]
30.09.2021Date on which the examining division has become responsible
10.10.2023Despatch of a communication from the examining division (Time limit: M04)
28.11.2023Reply to a communication from the examining division
27.03.2024Communication of intention to grant the patent
07.05.2024Fee for grant paid
07.05.2024Fee for publishing/printing paid
07.05.2024Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP09825609.2  / EP2355851
EP17001160.5  / EP3284482
Divisional application(s)EP23175192.6  / EP4241767
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
30.09.2021Request for further processing filed
30.09.2021Full payment received (date of receipt of payment)
Request granted
10.12.2021Decision despatched
The application is deemed to be withdrawn due to non-payment of designation fees
PL, TR, SM, SK, SI, SE, RO, PT, NO, NL, MT, MK, MC, LV, LU, LT, IT, IS, IE, HU, HR, GR, GB, FR, FI, ES, EE, DK, DE, CZ, CY, CH, BG, BE, AT
30.09.2021Request for further processing filed
30.09.2021Full payment received (date of receipt of payment)
Request granted
25.10.2021Decision despatched
The application is deemed to be withdrawn due to non-payment of the examination fee
30.09.2021Request for further processing filed
30.09.2021Full payment received (date of receipt of payment)
Request granted
25.10.2021Decision despatched
30.09.2021Request for further processing filed
30.09.2021Full payment received (date of receipt of payment)
Request granted
25.10.2021Decision despatched
Fees paidRenewal fee
04.06.2020Renewal fee patent year 03
04.06.2020Renewal fee patent year 04
04.06.2020Renewal fee patent year 05
04.06.2020Renewal fee patent year 06
04.06.2020Renewal fee patent year 07
04.06.2020Renewal fee patent year 08
04.06.2020Renewal fee patent year 09
04.06.2020Renewal fee patent year 10
04.06.2020Renewal fee patent year 11
13.11.2020Renewal fee patent year 12
26.10.2021Renewal fee patent year 13
30.11.2022Renewal fee patent year 14
24.11.2023Renewal fee patent year 15
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]DE3402146  (HENKEL KGAA [DE]);
 [I]US6320017  (ANSELL STEVEN MICHIAL [CA]);
 [E]WO2010042877  (TEKMIRA PHARMACEUTICALS CORP [CA], et al);
 [E]WO2010068816  (ALNYLAM PHARMACEUTICALS INC [US], et al)
by applicantUS3687808
 US3993754
 US4145410
 US4224179
 US4235871
 US4469863
 US4522803
 US4587044
 US4588578
 US4603044
 US4605735
 WO8604920
 WO8702062
 US4667025
 US4737323
 US4762779
 US4789737
 US4824941
 US4828979
 US4835263
 US4876335
 US4904582
 EP0360257
 US4948882
 US4957773
 US4958013
 US4987071
 WO9103162
 US5013556
 US5023243
 US5059528
 US5082830
 US5109124
 WO9207065
 US5112963
 US5116739
 US5118802
 US5130302
 US5138045
 US5142047
 US5149782
 WO9220822
 WO9220823
 US5168045
 US5177189
 US5177198
 US5182364
 US5214136
 US5218105
 US5223618
 WO9315187
 US5235033
 US5245022
 US5254469
 US5256775
 US5258506
 US5262536
 US5264562
 US5264564
 WO9323569
 US5272250
 WO9402595
 US5286634
 US5292873
 US5317098
 WO9413688
 US5334711
 US5359044
 US5366878
 US5371241
 US5378825
 US5386023
 US5391723
 US5414077
 US5416203
 US5451463
 US5457191
 US5459255
 US5473039
 US5476925
 US5484908
 US5486603
 US5489677
 US5508270
 WO9611266
 US5510475
 US5512439
 US5512667
 US5514785
 US5519134
 US5525472
 US5525465
 US5532130
 US5534499
 US5539083
 US5541313
 US5545730
 US5552538
 US5567810
 US5574142
 US5578717
 US5578718
 US5580731
 US5585481
 US5587371
 US5591317
 US5591584
 US5595726
 US5597696
 US5599923
 US5599928
 US5608046
 US5610288
 US5614617
 US5631359
 US5672685
 US5672662
 US5688941
 US5714166
 US5718709
 US5721114
 US5739119
 US5747470
 US5759829
 US5783683
 US5789573
 US5801154
 US5820873
 US5834596
 US5840688
 US5876968
 US5885613
 US5976567
 US6004925
 US6027726
 US6037323
 US6046166
 WO0044895
 US6153737
 US6172208
 US6287591
 US6300319
 WO0175164
 US6320017
 US6335434
 US6335437
 US6372886
 US6395437
 WO0244321
 US6444806
 US6486308
 US6525031
 US6528631
 US6559279
 US6858225
 WO2007095387
 WO2008036825
 US19790611131
 US19500611543
 US19390611714
 US19380611854
 US19980612258
 US19980612340
 WO1992US04294
 WO1992US04305
 EP19920110298
 US19950486214
 WO2004US07070
 US20040916185
 US20040946873
 US20050115989
 US20070657341
 US20070833934
 US20070944227
 US20090502158
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.